Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children

AIDS

Volumn 23, Issue 6, 2009, Pages 679-688

  Shostakovich Koretskaya, Ludmila ^a   Catano, Gabriel ^b,c   Chykarenko, Zoya A ^a   He, Weijing ^b,c   Gornalusse, German ^b,c   Mummidi, Srinivas ^b,c   Sanchez, Racquel ^b,c   Dolan, Matthew J ^d,e   Ahuja, Seema S ^b,c   Clark, Robert A ^b,c   Kulkarni, Hemant ^b,c   Ahuja, Sunil K ^b,c,f  

^a Dnipropetrovsk State Medical Academy   (Ukraine)

^b Veterans Administration   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d BROOKE ARMY MEDICAL CENTER   (United States)

^e HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

AIDS; CCL3L; CCL4L; HIV; Transmission

Indexed keywords

CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHILD; COHORT ANALYSIS; DISEASE PREDISPOSITION; GENE DUPLICATION; GENE NUMBER; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC TRANSCRIPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; PERINATAL PERIOD; PRIORITY JOURNAL; PROGENY; UKRAINE; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CHEMOKINE CCL3; CHEMOKINE CCL4; DISEASE PROGRESSION; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS; TERMINOLOGY AS TOPIC;

EID: 59249095595     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283270b3f     Document Type: Article

References (41)

1. Fauci AS, Johnston Ml, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, et al. HIV vaccine research: the way forward. Science 2008; 321:530-532.
2. Prendergast A, Tudor-Williams C, Jeena P, Burchett S, Goulder P. International perspectives, progress, and future challenges of paediatric HIV infection, Lancet 2007; 370:68-80.
3. Modi WS. CCL3L1 and CCL4L1 chemokine genes are located in a segmental duplication at chromosome 17q12. Genomics 2004; 83:735-738.
4. Modi WS, Bergeron J, Sanford M. The human MIP-1beta chemokine is encoded by two paralogous genes, ACT-2 and LAG-1. Immunogenetics 2001; 53:543-549.
5. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 2002; 13:455-481.
6. Nibbs RJ, YangJ, Landau NR, MaoJH, Graham GJ. LD78beta,a nonallelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity. J Biol Chem 1999; 274:17478-17483.
7. Struyf S, Menten P, Lenaerts JP, Put W, D'Haese A, De Clercq E, et al. Diverging binding capacities of natural LD78beta iso-forms of macrophage inflammatory protein-1 alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils. Eur J Immunol 2001; 31:2170-2178.
8. Xin X, Shioda T, Kato A, Liu H, Sakai Y, Nagai Y. Enhanced anti-HIV-1 activity of CC-chemokine LD78beta, a nonallelic variant of MIP-1alpha/LD78alpha. FEBS Lett 1999; 457:219- 222.
9. Colobran R, Adreani P, Ashhab Y, Llano A, Este JA, Dominguez O, et al. Multiple products derived from two CCL4 loci: nigh incidence of a new polymorphism in HIV+ patients. J Immunol 2005; 174:5655-5664.
10. Howard OM, Turpin JA, Goldman R, Modi WS. Functional redundancy of the human CCL4 and CCL4L1 chemokine genes. Biochem Biophys Res Commun 2004; 320:927-931.
11. Bailey JA, Gu Z, Clark RA, Reinert K, Samonte RV, Schwartz S, et al. Recent segmental duplications in the human genome. Science 2002; 297:1003-1007.
12. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al. Global variation in copy number in the human genome. Nature 2006; 444:444-454.
13. McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat Genet 2007; 39:S37-S42.
14. Sebat J. Major changes in our DNA lead to major changes in our thinking. Nat Genet 2007; 39:S3-S5.
15. Conrad DF, Hurles ME. The population genetics of structural variation. Nat Genet 2007; 39:S30-S36.
16. Lupski JR. An evolution revolution provides further revelation. BioEssays 2007; 29:1182-1184.
17. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273:1856-1862.
18. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382:722-725.
19. Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, et al. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998; 282:1907-1911.
20. Gonzalez E, Bamshad M, Sato N, Mummidi S, Dhanda R, Catano G, et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad 5ci USA 1999; 96:12004- 12009.
21. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17:657-700.
22. Kaslow RA, DorakT, TangJJ. Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis 2005; 191 (Suppl 1):S68-S77.
23. Mummidi S, Bamshad M, Ahuja SS, Gonzalez E, Feuillet PM, Begum K, et al. Evolution of human and nonhuman primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J Biol Chem 2000; 275:18946- 18961.
24. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005; 307:1434-1440.
25. Meddows-Taylor S, Donninger SL, Paximadis M, Schramm DB, Anthony FS, Gray GE, et al. Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission. J Gen Virol 2006; 87:2055-2065.
26. Kuhn L, Schramm DB, Donninger S, Meddows-Taylor S, Coovadia AH, Sherman GG, et al. African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS 2007; 21:1753-1761.
27. Nakajima T, Ohtani H, Naruse T, Shibata H, Mimaya Jl, Ter- unuma H, Kimura A. Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV- infected Japanese with hemophilia. Immunogenetics 2007; 59:793-798.
28. Sadam M, Karki T, Huik K, Avi R, Rüütel K, Uusküla A, Lutsar I. CCL3L1 variable gene copy number influence on the susceptibility to HIV-1/AIDS among Estonian intravenous drug user [abstract #296]. In: 15th Conference on Retroviruses and Opportunistic Infections 2008.
29. + T-cell responses and viral load in South African women. J Acquir Immune Defic Syndr 2008; 48:245-254.
30. Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, Anaya JM, et al. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol 2007; 8:1324-1336.
31. Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, et al. CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat Med 2008; 14:413-420.
32. Townson JR, Barcellos LF, Nibbs RJ. Gene copy number regulates the production of the human chemokine CCL3-L1. Eur J Immunol 2002; 32:3016-3026.
33. KetasTJ, KuhmannSE, Palmer A, Zurita J, He W, Ahuja SK, et al. Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands. Virology 2007; 364:281-290.
34. Degenhardt JD, de Candia P, Chabot A, Schwartz S, Henderson L, Ling B, et al. Copy number variation of CCL3-like genes affects rate of progression to simian-AIDS in rhesus macaques (Macaca mulatta). PLoS Genet 2009; 5:e1000346.
35. Colobran R, Comas D, Faner R, Pedrosa E, Anglada R, Pujol- Borrell R, et al. Population structure in copy number variation and SNPs in the CCL4L chemokine gene. Genes Immun 2008; 9:279-288.
36. Cardone MF, Jiang Z, D'Addabbo P, Archidiacono N, Rocchi M, Eichler EE, Ventura M. Hominoid chromosomal rearrangements on 17q map to complex regions of segmental duplication. Genome Biol 2008; 9:R28.
37. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-1409.
38. Cohen MS, Hellmann N, Levy JA, DeCock K, Lange J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest 2008; 118:1244-1254.
39. Kulkarni H, Marconi VC, Agan BK, McArthur C, Crawford G, Clark RA, et al. Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy. PLoS ONE 2008; 3:e3671.
40. Shao W, Tang J, Song W, Wang C, Li Y, Wi Ison CM, Kaslow RA. CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection. Genes Immun 2007; 8:224-231.
41. Gornalusse G, Mummidi S, He W, Silvestri G, Bamshad M, Ahuja SK. CCL3L copy number variation and the co-evolution of primate and viral genomes. PLoS Genet 2009; 5:e1000359.